Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tilray Brands Inc TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Comment by Ventura2020on Nov 10, 2023 12:42pm
112 Views
Post# 35728773

RE:Tilray Brands - German Cannabis Legalization Update

RE:Tilray Brands - German Cannabis Legalization Update

Boris has high hopes for International Operations. 
Dont blame him, that's where the growth is now.
TLRY completed the heavy lifting years ago. Tilray Pharma to sweep across European Union. With a far advanced footprint than most.

Boris Jordan: I'll start, and Ed, if you can address on the margin profile. So in Europe, our two main markets, as we said are the U.K. and Germany. We've just added Poland. Poland is ramping up very, very quickly. So we do expect to see further growth in the fourth quarter and the first quarter, it's a 41 million personal market. We expect margins to start to -- first of all, we expect the business to turn EBITDA positive, most likely in the fourth quarter. We also anticipate that with additional sales that we believe will happen in the first quarter with the pillar one German approval, which means basically the cannabis has been taken off the narcotics list. And therefore, we expect demand to increase substantially. We think somewhere around two to three times our current sales rate for next year on the back of that. With that obviously, as we start to lever our assets in Europe, specifically our growth and processing facilities in Portugal and Spain, we do anticipate that margins will improve throughout the year as revenue starts to accelerate in Europe.

<< Previous
Bullboard Posts
Next >>